RT-PCR confirmed SRF-NCOA2 fusion both in the tumor evaluated at diagnosis (T) and in the S-RMS1 cell line (Figure 1B) at different passages (passage 3 above panel, passage 7 below panel) as well as positivity for MyoD-1 and myogenin. This evidence concerns the gene NCOA2 and neoplasm.